With a valuation of USD 1.8 Billion in 2024, the global oral proteins and peptides market is set to grow to USD 3.4 Billion by 2033, reflecting a CAGR of 7.13% during 2025-2033, according to IMARC Group. North America, holding 97.8% of the market share in 2024, remains a key player. Growth is propelled by advancements in drug delivery systems and increasing demand for less invasive tr... https://www.imarcgroup.com/oral-proteins-peptides-market